Back to News
Market Impact: 0.5

Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's What You Should Know

PACKHIMSNDAQ
Analyst EstimatesAnalyst InsightsCompany FundamentalsCorporate EarningsInvestor Sentiment & Positioning
Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's  What You Should Know

Ranpak Holdings Corp (PACK) has recently surged 52.2% over the past four weeks, with a mean analyst price target of $7.17 suggesting a further 35.8% upside. While the article cautions against relying solely on analyst price targets due to their inherent variability and potential for bias, it highlights that PACK's more legitimate upside is supported by a 15.8% increase in its current year EPS consensus estimate over the past month and a Zacks Rank #2 (Buy), indicating strong positive earnings estimate revisions and analyst agreement on improved earnings prospects.

Analysis

Ranpak Holdings Corp. (PACK) has exhibited strong recent price momentum, gaining 52.2% over the past four weeks to a closing price of $5.28. While Wall Street's mean price target of $7.17 implies a potential 35.8% upside, this consensus is weakened by a high standard deviation of $2.57 and a wide range of estimates from a 5.3% decline to an 89.4% surge. The article itself suggests these targets should be viewed with skepticism due to potential analyst biases. The more compelling bullish signal for PACK, according to the analysis, is the positive trend in earnings estimate revisions. Specifically, the Zacks Consensus Estimate for the current year's EPS has increased by 15.8% over the past month, supported by one upward revision and no negative revisions. This is further substantiated by the stock's Zacks Rank #2 (Buy), which the source presents as a more conclusive, data-driven indicator of near-term upside potential based on the historically strong correlation between earnings estimate trends and stock price movements.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo